Publicaciones en colaboración con investigadores/as de University of Verona (142)

2024

  1. Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus

    BJS open, Vol. 8, Núm. 4

  2. Correction to: Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review (Infection, (2024), 52, 1, (43-58), 10.1007/s15010-023-02154-0)

    Infection

  3. Current management of SARS-CoV-2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey

    Transplant Infectious Disease, Vol. 26, Núm. 2

  4. Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

    Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97

  5. Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin

    Transplant Infectious Disease

  6. Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review

    Infection, Vol. 52, Núm. 1, pp. 43-58

  7. Methylomic signature of current cannabis use in two first-episode psychosis cohorts

    Molecular Psychiatry

  8. Self-reported suicidal ideation among individuals with first episode psychosis and healthy controls: Findings from the international multicentre EU-GEI study

    Schizophrenia Research, Vol. 270, pp. 339-348

  9. The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study

    Schizophrenia Bulletin, Vol. 50, Núm. 5, pp. 1039-1049

  10. The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe

    Psychological Medicine

  11. Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study

    Psychological medicine, Vol. 54, Núm. 8, pp. 1810-1823

2023

  1. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: Results from the EU-GEI case-control study

    Psychological Medicine, Vol. 53, Núm. 15, pp. 7375-7384

  2. Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 13, pp. 6150-6160

  3. Development and Validation of Predictive Model for a Diagnosis of First Episode Psychosis Using the Multinational EU-GEI Case-control Study and Modern Statistical Learning Methods

    Schizophrenia Bulletin Open, Vol. 4, Núm. 1

  4. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  5. Erratum : World Allergy Organization Anaphylaxis Guidance 2020 [Japanese Journal of Allergology Vol.70 (2021) No.9 p.1211-1234]

    Arerugi = [Allergy], Vol. 72, Núm. 3, pp. 314

  6. Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study

    Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106

  7. First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data

    Schizophrenia bulletin, Vol. 49, Núm. 1, pp. 218-227

  8. Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis

    Frontiers in Pharmacology, Vol. 14

  9. Measuring discrimination experienced by people with a mental illness: Replication of the short-form DISCUS in six world regions

    Psychological Medicine, Vol. 53, Núm. 9, pp. 3963-3973